149 related articles for article (PubMed ID: 37904416)
1. A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration.
Tang C; Qin L; Li J
Medicine (Baltimore); 2023 Oct; 102(43):e35732. PubMed ID: 37904416
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
[No Abstract] [Full Text] [Related]
3. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
[TBL] [Abstract][Full Text] [Related]
4. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
[TBL] [Abstract][Full Text] [Related]
5. A novel anoikis-related gene signature can predict the prognosis of hepatocarcinoma patients.
Yu X; Feng B; Wu J; Li M
Transl Cancer Res; 2024 Apr; 13(4):1834-1847. PubMed ID: 38737687
[TBL] [Abstract][Full Text] [Related]
6. An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning.
Guizhen Z; Weiwei Z; Yun W; Guangying C; Yize Z; Zujiang Y
Front Pharmacol; 2022; 13():1096472. PubMed ID: 36686684
[No Abstract] [Full Text] [Related]
7. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings.
Zhu S; Zhao Q; Fan Y; Tang C
BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825
[TBL] [Abstract][Full Text] [Related]
8. A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration.
Chi H; Jiang P; Xu K; Zhao Y; Song B; Peng G; He B; Liu X; Xia Z; Tian G
Front Genet; 2022; 13():984273. PubMed ID: 36092898
[No Abstract] [Full Text] [Related]
9. Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity.
Zhang D; Liu S; Wu Q; Ma Y; Zhou S; Liu Z; Sun W; Lu Z
Front Med (Lausanne); 2023; 10():1232814. PubMed ID: 37502362
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning.
Wang Q; Sun N; Zhang M
Int J Gen Med; 2023; 16():1833-1844. PubMed ID: 37213475
[TBL] [Abstract][Full Text] [Related]
11. The multi-omics analysis identifies a novel cuproptosis-anoikis-related gene signature in prognosis and immune infiltration characterization of lung adenocarcinoma.
Jiang G; Song C; Wang X; Xu Y; Li H; He Z; Cai Y; Zheng M; Mao W
Heliyon; 2023 Mar; 9(3):e14091. PubMed ID: 36967927
[TBL] [Abstract][Full Text] [Related]
12. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
Duan Y; Xu X
Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
[TBL] [Abstract][Full Text] [Related]
13. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
14. The Comprehensive Analysis of m6A-Associated Anoikis Genes in Low-Grade Gliomas.
Zheng H; Zhao Y; Zhou H; Tang Y; Xie Z
Brain Sci; 2023 Sep; 13(9):. PubMed ID: 37759912
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a novel anoikis-related gene signature for predicting prognosis in ovarian cancer.
Qian S; Wen Y; Mei L; Zhu X; Zhang H; Xu C
Aging (Albany NY); 2023 Apr; 15(9):3410-3426. PubMed ID: 37179119
[TBL] [Abstract][Full Text] [Related]
16. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract][Full Text] [Related]
17. An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration.
Shi J; Peng B; Zhou X; Wang C; Xu R; Lu T; Chang X; Shen Z; Wang K; Xu C; Zhang L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12089-12102. PubMed ID: 37421452
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
Yu Z; Zhu Y; Ji J
Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.
Liu Y; Shi Z; Zheng J; Zheng Z; Sun H; Xuan Z; Bai Y; Fu M; Du Y; Shao C
Front Immunol; 2023; 14():1171883. PubMed ID: 37056778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]